【学歴】
学士（薬学）岐阜薬科大学
修士（薬学）九州大学
博士（薬学）東北大学

【職歴】
製薬企業研究所、調剤薬局、東北大学病院薬剤部を経て現職

【資格】
日本医療薬学会　医療薬学指導薬剤師
日本臨床腫瘍薬学会　外来がん治療専門薬剤師

医療薬学

がんの個別化医療に向けた研究

【researchmap】
https://researchmap.jp/shimane

【主な原著論文】

1. Naoto Ishikawa, Hanae Oshikiri, Shinya Takasaki（責任著者）, Masafumi Kikuchi, Taku Obara, Kazutoshi Akasaka, Masaki, Matsuura, Hiroaki Yamaguchi, Nariyasu Mano
   Enhancement and evaluation of a prescription audit system for direct oral anticoagulants using a check sheet.
   J. Pharm. Health Care Sci., 2021;7(1):22.
2. Shinya Takasaki（責任著者）, Yoshihide Kawasaki, Masafumi Kikuchi, Akihiro Ito, Hiroaki Yamaguchi, Nariyasu Mano
   Clinical importance of blood drug concentration of oral molecular targeted drugs for renal cell carcinoma.
   J. Pharm. Pharm. Sci., 2021;24:127-136.
3. Shinya Takasaki（責任著者）, Tensei Hirasawa, Yu Sato, Masamitsu Maekawa, Taku Tsukamoto, Masafumi Kikuchi, Jiro Ogura, Yoshihiro Hayakawa, Yasushi Matsuda, Hisashi Oishi, Tetsu Sado, Masafumi Noda, Yoshinori Okada, Hiroaki Yamaguchi, Nariyasu Mano
   Simultaneous analysis of drugs administered to lung transplanted patients using liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.
   Biomed. Chromatogr., 2021;35(6):e5067.
4. Keiko Kurosawa, Shinya Takasaki（責任著者）, Hisaki Suzuki, Yuji Sato, Masatoshi Akiyama, Miki Akiba, Yoshikatsu Saiki, Nariyasu Mano
   A case of an increase in prothrombin time-international normalized ratio by interaction between warfarin and baloxavir marboxil in a patient on implantable ventricular assist device.
   J. Pharm. Pharm Sci., 2021;24:37-40.
5. Shinya Takasaki（責任著者）, Hisanobu Adachi, Yoshihide Kawasaki, Masafumi Kikuchi, Akihiro Ito, Nariyasu Mano
   Importance of therapeutic drug monitoring to detect drug interaction between pazopanib and warfarin: A case report.
   J. Pharm. Pharm. Sci., 2020;23:200-205.
6. Shinya Takasaki, Hiroaki Yamaguchi, Yoshihide Kawasaki, Masafumi Kikuchi, Masaki Tanaka, Akihiro Ito, Nariyasu Mano
   Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study.
   J. Pharm. Health Care Sci., 2019;5:6.
7. Shinya Takasaki, Yoshihide Kawasaki, Masafumi Kikuchi, Masaki Tanaka, Masato Suzuka, Aoi Noda, Yuji Sato, Shinichi Yamashita, Koji Mitsuzuka, Hideo Saito, Akihiro Ito, Hiroaki Yamaguchi, Yoichi Arai, Nariyasu Mano
   Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma.
   Int. J. Clin. Oncol., 2018;23(5):936-943.
8. Shinya Takasaki, Masaki Tanaka, Masafumi Kikuchi, Masamitsu Maekawa, Yoshihide Kawasaki, Akihiro Ito, Yoichi Arai, Hiroaki Yamaguchi, Nariyasu Mano
   Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
   Biomed. Chromatogr., 2018;32(6):e4184.
9. Shinya Takasaki（責任著者）, Masafumi Kikuchi, Yoshihide Kawasaki, Akihiro Ito, Yoichi Arai, Hiroaki Yamaguchi, Nariyasu Mano
   Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma.
   J. Med. Case Rep., 2017;11(1):28.
10. 髙﨑新也（責任著者）、菊地正史、川崎芳英、伊藤明宏、荒井陽一、山口浩明、眞野成康
    エベロリムス誘発肝機能障害により血中エベロリムス濃度高値と高血糖を示した腎細胞癌患者の1 例
    癌と化学療法, 2017;44(1):87-89.